Skip to main content
Log in

Pleural Sclerosis for the Treatment of Pneumothorax and Pleural Effusion

  • Published:
Lung Aims and scope Submit manuscript

Abstract.

Pleural sclerosis is indicated to obliterate the pleural space when one wants to prevent the recurrence of a spontaneous pneumothorax or the reaccumulation of a pleural effusion. Although many different agents ranging from antibiotics to antiseptics to antineoplastics to talc have been advocated, none is ideal. It is interesting that in the era when we are mapping the human genome, the agent most commonly used for pleurodesis is talc. Talc is very inhomogeneous, and the mechanisms by which it produces pleurodesis are unknown. In this review we will discuss the theory and mechanism of pleurodesis, the indications and contraindications for it, the advantages and disadvantages of the agents presently used for it, and our recommendations for the procedure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

Authors

Additional information

Accepted for publication: 4 February 1997

Rights and permissions

Reprints and permissions

About this article

Cite this article

Light, R., Vargas, F. Pleural Sclerosis for the Treatment of Pneumothorax and Pleural Effusion . Lung 175 , 213 –223 (1997). https://doi.org/10.1007/PL00007568

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/PL00007568

Navigation